<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709341</url>
  </required_header>
  <id_info>
    <org_study_id>00088481</org_study_id>
    <nct_id>NCT04709341</nct_id>
  </id_info>
  <brief_title>Transradial-Band Pilot Study</brief_title>
  <official_title>Optimization of Transradial-Band Removal Following Transradial Arterial Access for Interventional Radiology Diagnostic and Interventional Procedures (A Pilot Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the study group, the TR-Band will be in left in place for 15 minutes before it is&#xD;
      gradually deflated by 25% at 15 minute intervals. In the standard of care group, the TR-Band&#xD;
      is left in place for 60 minutes before it is gradually deflated by 25% at 15 minute&#xD;
      intervals. The aim of the study is to reduce the time the device is in place while minimizing&#xD;
      potential complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 3, 2021</start_date>
  <completion_date type="Anticipated">February 3, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 3, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants with significant hematomas</measure>
    <time_frame>an average of 12 hours post procedure</time_frame>
    <description>Hematoma &gt;5 cm in size</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants with significant hematomas</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>Hematoma &gt;5 cm in size</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants with bleeding</measure>
    <time_frame>an average of 12 hours post procedure</time_frame>
    <description>Continued ooze requiring re-inflation of the TR-Band or subcutaneous ecchymosis without a discernable hematoma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of participants with bleeding</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>Continued ooze requiring re-inflation of the TR-Band or subcutaneous ecchymosis without a discernable hematoma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left radial artery occlusion</measure>
    <time_frame>an average of 12 hours post procedure</time_frame>
    <description>Reduced or absence of radial artery blood flow based on ultrasound and Barbeau test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left radial artery occlusion</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>Reduced or absence of radial artery blood flow based on ultrasound and Barbeau test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Radial Artery Incision Site Closure</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TR Band 60MIN</intervention_name>
    <description>TR-Band will be in left in place for 15 minutes before it is gradually deflated by 25% at 15 minute intervals</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TR Band 120MIN</intervention_name>
    <description>TR-Band is left in place for 60 minutes before it is gradually deflated by 25% at 15 minute intervals</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years and older&#xD;
&#xD;
          -  Have an acceptable Barbeau test (i.e. type A through C)&#xD;
&#xD;
          -  Have acceptable coagulation parameters (based on PT, INR, platelet count, and&#xD;
             appropriate pre-procedural management of anticoagulants, See Table 1)&#xD;
&#xD;
          -  The caliber of the left radial artery based on a pre-procedure sonographic evaluation&#xD;
             will need to be greater than or equal to 1.6 mm.&#xD;
&#xD;
          -  The appropriate pre-procedural management of anticoagulants is based on the consensus&#xD;
             guidelines established by Patel et al16.&#xD;
&#xD;
          -  INR less than 1.5&#xD;
&#xD;
          -  Platelet count greater than 50,000 platelet/uL&#xD;
&#xD;
          -  Prothrombin time less than 15 seconds&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  If there is an unacceptable risk of bleeding diathesis, or&#xD;
&#xD;
          -  If he or she is not a suitable candidate for transradial access based on a Barbeau&#xD;
             test type D or a diameter of the left radial artery less than 1.6 mm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 12, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Ricardo Yamada</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

